Novel DNA-based T-Cell Activator Promotes Rapid T-Cell Activation and Expansion

Autologous chimeric antigen receptor engineered T-cell therapies are beginning to dramatically change the outlook for patients with several hematological malignancies. Yet methods to activate and expand these cells are limited, often pose challenges to automation, and have biological limitations imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Keskar, Vandana, Sood, Anup, Loghin, Evelina, Kovacs, Ernest, Duthie, R. Scott, Liu, Shutong, Park, Jee Hyun, Chadwick, Chrystal, Smith, Reginald, Brown, Martin, Stroncek, David F., Highfill, Steven L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Basic Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566300/
https://www.ncbi.nlm.nih.gov/pubmed/32796275
http://dx.doi.org/10.1097/CJI.0000000000000329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566300/
https://www.ncbi.nlm.nih.gov/pubmed/32796275
http://dx.doi.org/10.1097/CJI.0000000000000329

Ejemplares similares